Frequently Asked Questions

Technology transfer refers to the formal licensing of technology to third parties, under the guidance of professionals employed by universities, research foundations and businesses, in departments focused on these activities.

Tech Transfer at Yale University is done by Yale Ventures, which is composed of specialists in licensing, business development and intellectual property matters, who are widely experienced in developing and commercializing technologies from the life sciences, physical sciences, and engineering.

The reasons are unique to each researcher and may include:

• Making a positive impact on society!
• Achieving financial and recognition reward
• Generating additional lab/departmental funding
• Attracting research sponsorsMaking a positive impact on society
• Feeling a sense of personal fulfillment
• Meeting the obligations of a research or contract employment
• Creating educational opportunities for students
• Linking students to future job opportunities

Technology is typically transferred through a license agreement in which Yale grants its rights in the defined technology to a third party for a period of years, and sometimes for a particular field of use and/or region of the world. The licensee (the third party licensing the technology) may be an established company or a new business startup. Licenses include terms that require the licensee to meet certain performance requirements and to make financial payments to Yale. These payments are shared with the inventors, Yale and other institutions in the case of jointly owned inventions, to provide support for further research, education and participation in the tech transfer process.

The U.S. Bayh-Dole Act of 1980 allows universities and other non-profit institutions to elect ownership rights to discoveries resulting from federally funded research, provided certain obligations are met. These obligations include making efforts to protect (when appropriate) and commercialize the discoveries, submitting progress reports to the funding agency, giving preference to small businesses that demonstrate sufficient capability, and sharing any resulting revenues with the inventors. The Bayh-Dole Act is credited with stimulating interest in tech transfer activities and generating increasing research, commercialization, educational opportunities and economic development.

The process of technology transfer is summarized in the steps that follow. Note that these steps can vary in sequence and often occur simultaneously.

1. Research: Observations and experiments during research activities often lead to discoveries and inventions. An invention is any useful process, machine, composition of matter, or any new or useful improvement of the same. Often, multiple researchers may have contributed to the invention.
2. Pre-Disclosure: An early contact with Yale Ventures personnel to discuss your invention and to provide guidance with respect to the disclosure, evaluation, and protection processes described below.
3. Invention Disclosure: The written notice of invention to Yale Ventures that begins the formal technology transfer process. An invention disclosure remains a confidential document, and should fully document your invention so that the options for commercialization can be evaluated and pursued. An invention disclosure should be ideally be submitted before any disclosure of your technology outside of the Yale community.
4. Assessment: The period in which you and your Yale Ventures representative review the invention disclosure, conduct patent searches (if applicable), and analyze the market and competitive landscape to determine the invention’s commercialization potential. The evaluation process, which may lead to a broadening or refinement of the invention, will guide our strategy on whether to focus on licensing to an existing company or creating a new business startup.
5. Protection: The process in which protection for an invention is pursued to encourage third party interest in commercialization.Patent protection, a common legal protection method, begins with the filing of a patent application with the U.S. Patent Office and, when appropriate, foreign patent offices. Once a patent application has been filed, it will require several years and many thousands of dollars to obtain issued U.S. and foreign patents. Other protection options include copyright and trademark protection.
6. Marketing: With your active involvement, Yale Ventures staff will identify candidate companies that have the expertise, resources, and business networks to bring the technology to market. This may involve partnering with an existing company or forming a startup. Your active involvement can dramatically shorten this process.
7. Form a Startup: If creation of a new business startup has been chosen as the optimal commercialization path, Yale Ventures’ Director of New Ventures will assist in planning, creating and funding the startup.
8. Existing Business Relationship: If an appropriate and interested existing business is identified as a potential licensee, Yale Ventures licensing specialists identify mutual interests, goals and plans to fully commercialize this technology through a license agreement.
9. Licensing: A license agreement is a contract between Yale and a third party in which Yale’s rights to a technology are licensed (without relinquishing ownership) for financial and other benefits. A license agreement is used with both a new startup business or with an established company. An option agreement is sometimes used to enable a third party to evaluate the technology for a limited time before licensing.
10. Commercialization: The licensee company continues the advancement of the technology, and makes other business investments to develop the product or service. This step may entail further development, regulatory approvals, sales and marketing, support, training, and other activities.
11. Revenue: Set portions of the revenues received by Yale from licensees are distributed to the inventors, Yale and other institutions (in the case of jointly owned inventions) to fund additional research and education and to encourage further participation in the tech transfer process.

We encourage you to contact Yale Ventures during your discovery process to ensure you are aware of the options that will help maximize the commercial potential of your research. Yale Ventures staff members will assist you with questions related to marketability, funding sources, commercial partners, patenting and other protection methods, new business startup considerations, Yale policies and procedures, and much more.

The process of protecting the technology and finding the right licensing partner may take months—or even years—to complete. The amount of time will depend on the development stage of the technology, the market for the technology, competing technologies, the amount of work needed to bring a new concept to market-ready status, and the resources and willingness of the licensees and the inventors.

Yes. However, you must be sure that you have the right to do so if the materials have been provided under an MTA or a license. It is imperative to document items that are to be shared with others and the conditions of use. If you wish to send materials to an outside collaborator, an outgoing Material Transfer Agreement (MTA) should be completed for this purpose. It also may be necessary to have a Confidentiality Agreement completed to protect your research results or intellectual property. Please contact Yale Venture for assistance completing outgoing and incoming MTAs.

The Sponsored Research Agreement should specify the intellectual property (IP) rights of the sponsor. Yale generally retains ownership of the patent rights and other intellectual property resulting from sponsored research. However, the sponsor may have rights to obtain a license to the defined and expected outcomes of the research. Often, sponsored research contracts allow the sponsor a limited time to negotiate a license for any patent or intellectual property rights developed as the result of the research. Even so, the sponsor generally will not have contractual rights to discoveries that are clearly outside of the scope of the research. Therefore, it is important to define the scope of work within a research agreement. Sponsored research projects may be handled by Yale Ventures, but they are more typically negotiated by Grants and Contracts. Yale Ventures works with Grants and Contracts to clarify IP issues in sponsored research agreements.

When researchers enter into consulting agreements, they are deemed to be acting outside of the scope of their employment. Therefore consulting arrangements are not negotiated by Yale. Researchers who enter into consulting agreements should familiarize themselves with Yale Policies on consulting and make sure that they are first in compliance with the terms of the consulting agreement. The researcher is expected to ensure that the terms of the consulting arrangement are consistent with Yale policies, including those related to IP ownership, employment responsibilities and use of Intellectual Property. Yale Ventures is available to provide informal advice on how your consulting agreement relates to your intellectual property.

Yes, but since patent rights are affected by these activities, it is best to submit an Invention Disclosure (discussed in next section) well before any public communication or disclosure of the invention. This will maximize the intellectual property options for your potential invention.

There are significant differences between the U.S. and other countries as to how early publication affects a potential patent. Once publicly disclosed (published or presented in some form), you have only 12 months to file a U. S. patent application. Additionally an invention is publicly disclosed without patent protection may have restricted or minimal potential for patent protection outside of the United States. Be sure to inform Yale Ventures of any imminent or prior presentation, lecture, poster, abstract, website description, research proposal submission, dissertation/Master’s thesis, publication, or other public presentation of the invention.

Yes, though there may be restrictions on the use or the rights to inventions if the intellectual property is being provided under a Material Transfer Agreement (MTA). It is important to document carefully the date and conditions of use so that we can determine if this use may influence the ownership rights of your subsequent research results. If you wish to obtain materials from outside collaborators, an incoming MTA should be completed. In some cases, there may be restrictions placed on the use of materials provided by companies, even if the materials are purchased.
 

An Invention Disclosure (ID) is a description of your invention or development that is provided to Yale Ventures. The ID lists all collaborating sources of support and includes information necessary to begin pursuing protection and commercialization activities. To initiate the process, please disclose your invention online or email, fax or hand deliver the fully signed Invention Disclosure to Yale Ventures. This document will be treated as “confidential.” Using the Disclosure, Yale Ventures can then generate a non-confidential description of your invention to assist in marketing the technology and creating confidentiality agreements with outsiders to allow more detailed exchanges of information with potential partners.

When you disclose your invention to Yale Ventures, it starts a process that could lead to the commercialization of your technology. On the part of Yale Ventures, this may involve beginning the legal protection process and working to identify outside development partners. If government funds were used for your research, you are required to file a prompt disclosure. Similar requirements may exist for other sponsored projects.

You are encouraged to submit your innovation via our I have an idea form for all inventions and developments that you feel may solve a significant problem and/or have significant value. If you are in doubt, contact Yale Ventures business development team to discuss the invention. We can also advise on alternatives to licensing. 

You can submit an Idea whenever you feel you have discovered something unique with possible commercial value. This should be done well before presenting the discovery through publications, poster sessions, conferences, press releases, or other communications. Once publicly disclosed (i.e., published or presented in some form), an invention may have restricted or minimal potential for patent protection outside of the United States. Differences exist between the U.S. and other countries on the impact of early publication on a potential patent. For example, once you have presented the information publicly or the abstract has been made available publicly, your invention is not patentable in many countries. Be sure to inform Yale Ventures of any imminent or prior presentation, lecture, poster, abstract, website description, research proposal, dissertation/Master’s thesis, publication, or other public presentation of the invention.

Typically, research tools are materials such as antibodies, vectors, plasmids, cell lines, mice, and other materials used as “tools” in the research process. Research tools do not necessarily need to be protected by patents in order to be licensed to commercial third parties and generate revenue for your laboratory. If you have research tools that you believe to be valuable, or wish to provide to others (including research collaborators), Yale Ventures will work with you to develop the appropriate protection, licensing and distribution strategy.

You can submit an Idea through our “I have an idea” button. Complete your submission and someone from Yale Ventures will be in touch with you within a week. If a disclosure is necessary, we will send you the link or form to fill out.  

Intellectual property is material that may be protected under the patent, trademark and/or copyright laws.

Ownership depends upon the employment status of the creators of the invention and their use of Yale resources or facilities. Considerations include:

• What is the source of the funds or resources used to produce the invention?
• What was the employment status of the creators at the time the intellectual property was made?
• What are the terms of any agreement related to the creation of the intellectual property?
  As a general rule, the Yale owns inventions made by its employees while acting within the scope of their employment or using Yale resources. In some cases, the terms of a Sponsored Research Agreement or Materials Transfer Agreement may impact ownership. When in doubt, it is best to call Yale Ventures for advice.

The ownership of inventions made while consulting for an outside company depends on the terms of your consulting contract which should indicate that inventions typically are owned by your primary employer. It is important to clearly define the scope of work within consulting contracts to minimize any issues with inventions from Yale research.

If you have questions, Yale Ventures is available for informal advice.

All contributors to the ideas leading to a discovery should be mentioned in your disclosure, even if they are not Yale employees. Yale Ventures, along with legal counsel, will determine the rights of such persons and institutions. It is prudent to discuss with Yale Ventures all working relationships (preferably before they begin) to understand the implications for any subsequent inventions.

Yes, a student can even be the sole contributor or inventor. The ownership of an invention developed with or by a student depends on 1) whether the invention was created by a student in a capacity as a Yale employee and 2) whether the invention was created using Yale resources. The Yale owns, at least in part, any invention created by a student employee with Yale resources.

Yale Ventures examines each invention disclosure to review the novelty of the invention, patentability and marketability of potential products or services, relationship to related intellectual property, size and growth potential of the relevant market, amount of time and money required for further development, pre-existing rights associated with the intellectual property (IP), and potential competition from other products/technologies.

This assessment may also include consideration of whether the intellectual property can be the basis for a new business startup.

If Yale decides that it does not wish, and has no legal obligation, to participate in the patenting or licensing of an invention, Yale may release its interest in the invention to the inventor(s) in exchange for a share of any future income and the right to practice the invention for Yale’s research and educational purposes. Such a release will require the agreement of all inventors. Reassignment of inventions funded by the U.S. government may also require the government’s prior approval.

In the U.S., a patent gives the patent holder has the right to exclude others from making, using, selling, offering to sell, and importing any patented invention. Thus, a patent does not necessarily provide the holder any affirmative right to practice a technology. Instead, it provides the right to exclude others from practicing it. Patent claims are the legal definition (often called the “metes and bounds”) of an inventor’s protectable invention.

Copyright is a form of protection provided by the laws of the United States to the authors of “original works of authorship.” This includes literary, dramatic, musical, artistic, and certain other intellectual works as well as computer software. This protection is available to both published and unpublished works. The Copyright Act generally gives the owner of copyright the exclusive right to conduct and authorize various acts, including reproduction, display, distribution, public performance and making derivative works.

Copyright protection is automatically secured when a work is fixed into a tangible medium such as a book, software code, video, etc.

Patentable subject matter includes any new and useful processes, machines, compositions of matter, some computer programs, and methods (including methods of making compositions, methods of making articles, and even methods of performing business).

No. A natural substance that has never before been isolated or known may be patentable in some instances, but only in its isolated form (since the isolated form had never been known before). A variation of a naturally occurring substance may be patentable if an inventor is able to demonstrate substantial advantages of using the variant.

The PTO is the federal agency, organized under the Department of Commerce, that administers patents and trademarks on behalf of the government. The PTO employs patent examiners skilled in all technical fields in order to appraise patent applications. The PTO also issues federal trademark registrations.

An inventor is someone who has made an intellectual contribution to the claimed invention. Under U.S. law, an inventor is a person who takes part in the conception of the ideas in the patent claims of a patent application. Thus, inventorship of a patent application may change as the patent claims are changed during prosecution of the application. An employer or person who furnishes money to build or practice an invention is not an inventor. Inventorship is not something that can be negotiated.

Inventorship may require an intricate legal determination by the patent attorney prosecuting the application. Inventorship is often more restricted than authorship, thus it is important to note that authorship on an academic publication does not necessarily equate to inventorship on a patent application.

Yale Ventures contracts with outside counsel for IP protection, thus assuring access to patent specialists in diverse technology areas. Inventors work with the patent counsel in drafting the patent applications and responses to worldwide patent offices. Yale Ventures will help with the selection and oversight of the outside patent counsel.

Patent applications are generally drafted by a patent attorney or a patent agent (a non-attorney with a science education licensed to practice by the PTO). The patent attorney generally will ask you to review an application before it is filed and will also ask you questions about inventorship of the application claims. At the time an application is filed, the patent attorney will ask the inventor(s) to sign an Inventor’s Declaration and an Assignment, which memorializes the inventor’s pre-existing duty to assign the patent to Yale. In about one year, depending on the technology, the patent attorney will receive written notice from the PTO as to whether the application and its claims have been accepted in the form as filed. More often than not, the PTO rejects the application because either certain formalities need to be cleared up, or the claims are not patentable over the “prior art” (anything that workers in the field have made or publicly disclosed in the past). The letter sent by the PTO is referred to as an Office Action or Official Action. If the application is rejected, the patent attorney must file a written response, usually within three to six months. Generally the attorney may amend the claims and/or point out why the PTO’s position is incorrect. This procedure is referred to as patent prosecution. Often it will take two PTO Official Actions and two responses by the patent attorney—and sometimes more—before the application is resolved. The resolution can take the form of a PTO notice that the application is allowable; in other words, the PTO agrees to issue a patent. During this process, input from the inventor(s) is often needed to confirm the patent attorney’s understanding of the technical aspects of the invention and/or the prior art cited against the application. The PTO holds patent applications confidential until published by the PTO, which occurs 18 months after initial filing.

No. However, there is a provisional application for a patent, which is described below.

In certain circumstances, U.S. provisional applications can provide a tool for preserving patent rights while temporarily reducing costs. This occurs because the application is not examined during the year in which it is pending and claims are not required. A regular U.S. application and related foreign applications must be filed within one year of the provisional form in order to receive its early filing date. However, an applicant only receives the benefit of the earlier filing date for material that is described and enabled in the provisional application. As a result, the patent attorney may need your assistance when an application is filed as a provisional. What’s different about foreign patent protection?

Foreign patent protection is subject to the laws of each individual country, although in a general sense the process works much the same as it does in the United States. In foreign countries, however, an inventor will lose any patent rights if he or she publicly discloses the invention prior to filing the patent application. In contrast, the United States has a one-year grace period.

Although an international patent does not exist, an international agreement known as the Patent Cooperation Treaty (PCT) provides a streamlined filing procedure for most industrialized nations. For U.S. applicants, a PCT application is generally filed one year after the corresponding U.S. application (either provisional or regular) has been submitted. The PCT application must later be filed in the national patent office of any country in which the applicant wishes to seek patent protection, generally within 30 months of the earliest claimed filing date.

A PCT application provides two advantages. First, it delays the need to file costly foreign applications until the 30-month date, often after an applicant has the opportunity to further develop, evaluate and/or market the invention for licensing. Second, the international preliminary examination often allows an applicant to simplify the patent prosecution process by having a single examiner speak to the patentability of the claims, which can save significant costs in prosecuting foreign patent applications.

An important international treaty called the Paris Convention permits a patent application filed in a second country (or a PCT application) to claim the benefit of the filing date of an application filed in a first country. However, pursuant to this treaty, these so-called “convention applications” must be filed in foreign countries (or as a PCT) within one year of the first filing date of the U.S. application.

Currently, the average U.S. utility patent application is pending for about two years, though inventors in the biotech and computer fields should plan on a longer waiting period. Once a patent is issued, it is enforceable for 20 years from the initial filing of the application that resulted in the patent, assuming that PTO-mandated maintenance fees are paid.

Patent protection is often a requirement of a potential commercialization partner licensee because it can protect the commercial partner’s often sizable investment required to bring the technology to market. Due to their expense, patent applications are not possible for all intellectual property. We carefully review the commercial potential for an invention before investing in the patent process.

However, because the need for commencing a patent filing usually precedes finding a licensee, we look for creative and cost-effective ways to seek early protection for as many promising inventions as possible.

Yale Ventures and the inventor(s) consider relevant factors in making recommendations about filing patent applications. Ultimately, the Yale Ventures Licensing Team makes the final decision as to whether to file a patent application or seek another form of protection.

Filing a regular U.S. patent application may cost between $5,000 and $10,000. Obtaining an issued patent may require an additional $5,000 to $15,000 for patent prosecution, or more depending on the amount and nature of prior art in the field. Filing and obtaining issued patents in other countries may cost $20,000 or more per country. Also, once a patent is issued in the U.S or in foreign countries, certain maintenance or annuity fees are required to keep the patent alive.

If you created the invention under a contract or consulting agreement with a company, the Yale Ventures licensing manager will need to review that contract to determine ownership and other rights associated with the contract, and to determine the appropriate next steps.

Should the technology be jointly owned, Yale Ventures will work with other organizations under “inter-institutional” agreements that provide for one of the institutions to take the lead in protecting and licensing the invention, sharing of expenses associated with the patenting process, and allocating any licensing revenues.

Often Yale accepts the risk of filing a patent application before a licensee has been identified. After Yale’s rights have been licensed to a licensee, the licensee generally assumes the patenting expenses. At times we must decline further patent prosecution after a reasonable period (often a year or two) of attempting to identify a licensee.

A startup is a new business entity formed to commercialize one or more related intellectual properties. Forming a startup business is an alternative to licensing the IP to an established business. A few key factors when considering a startup company are:

• Development risk (often large companies in established industries are unwilling to take the risk)
• Development costs versus investment return (can the investors realize an attractive return on their investment?)
• Potential for multiple products or services from the same technology (few companies survive on one product alone)
• Sufficiently large competitive advantage and target market
• Potential revenues sufficient to sustain and grow a company
• Yale Ventures can help evaluate these and other factors.

The choice to establish a new company for commercializing IP is a joint decision made by Yale Ventures and the inventors. If a new business startup appears to be an preferred commercialization path, Yale Ventures will assist you in planning and executing the process. Please reach out to YaleVentures@yale.edu. 

Yale University’s faculty typically serve as technology consultant, advisor or in some other technical developmental capacity. Some university faculty choose to play founding roles in the formation and financing of companies. Rarely does Yale’s faculty choose to leave Yale and join the startup. In many cases, the faculty role is suggested by the startup investors and management team who identify the best role based on the inventor’s expertise and interests. As the company matures, and additional investment is required, the inventor’s role may change. Yale University’s faculty involvement of any kind in a startup is also reviewed by Yale’s Conflict of Interest Committee. Student inventors and postdocs may choose to join the startup upon graduation but typically will partner with more experienced business executives to manage the new company.

Starting a company requires a considerable amount of time and effort. Until the startup team is identified and engaged, the faculty member will need to champion the formation effort. After the team is in place, effort is required for investor discussions, formal responsibilities in or with the company, and Yale processes such as conflict of interest reviews.

Yale often co-founds companies with faculty and/or outside business partners, and, like other founders, will receive founders stock in a company that is separate from any license consideration. The decision to enter into such a partnership and the determination of relative ownership stakes are made only when by mutual agreement of all parties involved.

No. As a separate entity, the startup pays for its own legal matters, including all business incorporation matters and licensing expenses.

In addition to corporate counsel, the startup may have its own intellectual property counsel to assist with corporate patent strategy, especially if the company will be involved in a patent-rich area.

The startup’s counsel must be separate from Yale counsel, though it is advisable and recommended that the corporate IP Counsel and the Patent Counsel coordinates activities. Also, it is wise for inventors to have agreements regarding their roles with the startup reviewed by their own counsel to ensure that all personal ramifications—including taxation and liabilities—are clearly understood.

A license is a permission that the owner or controller of intellectual property grants to another party, usually under a license agreement.

License agreements describe the rights and responsibilities related to the use and exploitation of intellectual property developed at Yale. Yale license agreements usually stipulate that the licensee will diligently seek to bring the intellectual property into commercial use for the public good and provide a reasonable return to Yale.

A licensee is chosen based on its ability to commercialize the technology for the benefit of the general public. Sometimes an established business with experience in similar technologies and markets is the best choice. In other cases, the focus and intensity of a startup company is a better option.

Per Yale’s policies on intellectual property, a set share ranging from 30% to 50% of any net financial return from a license is provided to the inventor(s). View more information on Yale’s policies. Most inventors enjoy the satisfaction of knowing their inventions are being commercialized and deployed for the benefit of the general public. New or enhanced relationships with businesses is another outcome that can augment one’s teaching, research and consulting.

Most licensees require the active assistance of the inventor to facilitate their commercialization efforts. This can range from infrequent, informal contacts to a more formal consulting relationship. Working with a new business startup can require substantially more time, depending on your role in or with the company and your continuing role within Yale. Your participation with a startup is governed by Yale’s conflict of interest policies and the approval of your supervisor. View more information on Yale’s policies on conflict of interest.

• Non-Disclosure Agreements (NDAs), also known as Confidential Disclosure Agreements (CDAs), are often used to protect the confidentiality of an invention during evaluation by potential licensees. NDAs/CDAs also protect proprietary information of third parties that Yale researchers need to review in order to conduct research, or evaluate research opportunities. Yale Ventures enters into NDAs/CDAs for Yale proprietary information shared with someone outside of Yale.
• Inter-Institutional Agreements describe the terms under which two or more institutions (e.g., two universities) will collaborate to assess, protect, market, license, and share in the revenues received from licensing jointly owned intellectual property.
• Option Agreements, or Option Clauses within research agreements, describe the conditions under which Yale preserves the opportunity for a third party to negotiate a license for intellectual property. Option clauses are often provided in a Sponsored Research Agreement to corporate research sponsors at Yale, or are entered into with third parties wishing to evaluate the technology prior to entering into a full license agreement.
• Material Transfer Agreements (MTAs), used for incoming and outgoing materials at Yale, are administered by Yale Ventures when the other party is a for-profit entity. These agreements describe the terms under which Yale researchers and outside researchers may share materials, typically for research or evaluation purposes. Intellectual property rights can be jeopardized if materials are transferred and used without a proper MTA.
• Sponsored Research Agreements (SRAs) or Collaboration Research Agreements (CRAs) with for-profit organizations are also negotiated by Yale Ventures. These agreements include provisions that address how intellectual property, which may arise out of the research, will be handled.

Studies have shown that 70% of licensees were known to the inventors. Thus research and consulting relationships are often a valuable source for licensees. Licensees are also identified through existing relationships of the Yale Ventures staff. We attempt to broaden these relationships through contacts obtained from website posting inquiries, market research, industry events and the cultivation of existing licensing relationships.

It can take months and sometimes years to locate a potential licensee, depending on the attractiveness of the invention, its stage of development, and the size and intensity of the market. Most Yale inventions tend to be in the early stage in the development cycle and thus require substantial commercialization investment, making it more difficult to attract a licensee.

Your active involvement can dramatically improve the chances of matching an invention to an outside company. Your research and consulting relationships are often helpful in both identifying potential licensees and technology champions within companies. Once interested companies are identified, the inventor is the best person to describe the details of the invention and its technical advantages. The most successful tech transfer results are obtained when the inventor and the licensing professional work together as a team to market and sell the technology.

Yes, an invention can be licensed to multiple licensees, either non-exclusively to several companies or exclusively to several companies, each only for a unique field-of-use (application) or geography.

The licensing team at Yale Ventures uses many sources and strategies to identify potential licensees and market inventions. Sometimes existing relationships of the inventors, the Yale Ventures staff, and other researchers are useful in marketing an invention. Market research using subscription-based database tools can also assist in identifying prospective licensees. In addition, we also examine other complementary technologies and agreements to assist our efforts. We use various websites to reference inventions, leverage conferences and industry events, and make direct contacts. Faculty publications and presentations are often excellent marketing tools as well.

Most licensees continue to develop an invention to enhance the technology, reduce risk, prove reliability, and satisfy the market requirements for adoption by customers. This can involve additional testing, prototyping for manufacturability, durability and integrity, and further development to improve performance and other characteristics. Documentation for training, installation and marketing is often created during this phase. Benchmarking tests are often required to demonstrate the product/service advantages and to position the product in the market.

Your role can vary depending on your interest and involvement, in the interest of the licensee in utilizing your services for various assignments, and any contractual obligations related to the license or any personal agreements.

Most licenses have licensing fees that can be very modest (for startups or situations in which the value of the license is deemed to warrant a modest license fee) or can reach hundreds of thousands of dollars. Royalties on the eventual sales of the licensed products can generate similar revenues, although this can take years to occur. Equity, if included in a license, can yield similar returns, but only if a successful equity liquidation event (public equity offering or a sale of the company) occurs. Most licenses do not yield substantial revenues. A recent study of licenses at U.S. universities demonstrated that only 1% of all licenses yield over $1 million. However, the rewards of an invention reaching the market are often more significant than the financial considerations alone.

Licenses typically include performance milestones that, if unmet, can result in termination. This allows for subsequent licensing to another business. However, time delays and other considerations can hinder this effort.

A conflict of interest can occur when a Yale employee, through a relationship with an outside organization, is in a position to:

1. influence Yale’s business, research or other areas that may lead to direct or indirect financial gain,
2. adversely impact or influence one’s research or teaching responsibilities, or
3. provide improper advantage to others, to the disadvantage of Yale.

Examples include the appropriate and objective use of research, the treatment and roles of students, supervision of individuals working at both Yale and a licensee company, and conflict of commitment (i.e., your ability to meet your Yale obligations).

A conflict of commitment may exist if duties, assignments or responsibilities associated with a technology license or outside business arrangement have a negative impact on your ability to meet commitments associated with your Yale employment or exceed the amount of time available to you for these activities. The best approach is to fully disclose your situation to your supervisor and discuss the implications for your job responsibilities.

Yale Ventures representatives can advise you on conflict of interest issues. It is the responsibility of the researcher or faculty member to disclose and document any outside arrangements that constitute disclosable situations or interests as described in Yale conflict of interest policies. View Yale’s policy and guidelines regarding Conflict of Interest.  

Yale Ventures is responsible for managing the expenses and revenues associated with technology agreements. Per Yale Ventures Intellectual Patent Policy, revenues from license fees, royalties and equity—minus any un-reimbursed patenting and filing expenses—are shared with the inventors, laboratory(ies), department(s) and sponsors such as HHMI.

License revenues are typically taxed as Form 1099 income. Consult a tax advisor for specific advice.

Revenues waived by inventors are distributed to the associated department/laboratory. To avoid potential tax liability, revenues waived by you to your department/unit must not be under your control. 

When Yale equity is liquidated by Yale Ventures, the resulting funds are distributed in accordance with Yale’s royalty distribution plan. Shares of publicly traded businesses may be distributed to inventors before liquidation.